Literature DB >> 16705756

Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice.

Mario G Moreno1, Pablo Muriel.   

Abstract

The aim of the present work was to investigate the role of inducible nitric oxide (NO) synthase (iNOS) in CCl(4)-induced cirrhosis by utilizing iNOS knock out mice (iNOS(-/-)). Cirrhosis was produced by i.p. administration of CCl(4) (1 ml kg(-1) of body weight) dissolved in olive oil three times a week for 3 months to iNOS(-/-) or iNOS(+/+) (wild type) mice; appropriate olive oil controls were performed. Nitrite plus nitrate levels were lower in iNOS(-/-) compared with iNOS(+/+) mice, but CCl(4) did not produce a significant effect in any mice. Reduced (GSH) glutathione was increased in iNOS(-/-) mice receiving vehicle and in both groups receiving CCl(4); lipid peroxidation increased significantly in iNOS(+/+) but not in iNOS(-/-) mice. Bilirubins, alanine aminotransferase and collagen (measured as the hepatic hydroxyproline content) were increased significantly by the chronic intoxication with CCl(4) in both iNOS(-/-) and iNOS(+/+) mice; importantly there was no difference between these groups. This study clearly suggests that NO derived from iNOS does not participate in cholestasis, necrosis or fibrosis induced by CCl(4) in the mice. The present results are in disagreement with several studies indicating a beneficial or detrimental effect of this molecule utilizing different experimental approaches and in agreement with some studies indicating that NO does not affect liver damage in some models. It must be pointed out that this is the first report in iNOS knock out mice utilizing the chronic model of intoxication with CCl(4); thus, comparisons with other models or approaches are difficult to reconcile. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705756     DOI: 10.1002/jat.1144

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  5 in total

1.  TGF-beta and mesenchymal hepatic involvement after visceral leishmaniasis.

Authors:  Maria Irma Seixas Duarte; Heitor Franco de Andrade; Cleusa Fumica Hirata Takamura; Antonio Sesso; Felipe Francisco Tuon
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

2.  Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.

Authors:  Sura Wanessa Santos Rocha; Maria Eduarda Rocha de França; Gabriel Barros Rodrigues; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; André Filipe Pastor; Anne Gabrielle Vasconcelos Oliveira; Wilma Helena Oliveira; Rayana Leal Almeida Luna; Christina Alves Peixoto
Journal:  Mediators Inflamm       Date:  2014-10-13       Impact factor: 4.711

3.  L-Carnitine ameliorates the liver by regulating alpha-SMA, iNOS, HSP90, HIF-1alpha, and RIP1 expressions of CCL4-toxic rats.

Authors:  Derya Karabulut; Ali Tugrul Akin; Murat Unsal; Ayça Lekesizcan; Tuğçe Merve Ozyazgan; Didem Barlak Keti; Birkan Yakan; Görkem Ekebas
Journal:  Iran J Basic Med Sci       Date:  2021-02       Impact factor: 2.699

4.  Activin B promotes the initiation and progression of liver fibrosis.

Authors:  Yan Wang; Matthew Hamang; Alexander Culver; Huaizhou Jiang; Jennifer Yanum; Veronica Garcia; Joonyong Lee; Emily White; Praveen Kusumanchi; Naga Chalasani; Suthat Liangpunsakul; Benjamin C Yaden; Guoli Dai
Journal:  Hepatol Commun       Date:  2022-07-22

5.  Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.

Authors:  Akanksha Sharma; Alok K Verma; Matthew Kofron; Ramesh Kudira; Alexander Miethke; Tong Wu; Jiang Wang; Chandrashekhar R Gandhi
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.